MedPath

UNITHER PHARMACEUTICALS

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:0

Trial Phases

3 Phases

Phase 1:1
Phase 2:2
Phase 3:1

Drug Approvals

1

CIMA_AEMPS:1

Drug Approvals

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (50.0%)
Phase 1
1 (25.0%)
Phase 3
1 (25.0%)

Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment

Phase 2
Terminated
Conditions
Ovarian Cancer
First Posted Date
2004-07-09
Last Posted Date
2007-12-18
Lead Sponsor
Unither Pharmaceuticals
Target Recruit Count
40
Registration Number
NCT00086632

Clinical Trial for Ovarian Cancer (OvaRex®)

Phase 3
Terminated
Conditions
Ovarian Cancer
First Posted Date
2002-12-06
Last Posted Date
2007-12-18
Lead Sponsor
Unither Pharmaceuticals
Target Recruit Count
354
Registration Number
NCT00050375
Locations
🇺🇸

Comprehensive Cancer Institute, Huntsville, Alabama, United States

🇺🇸

Western Regional Community Clinical Oncology Program, Phoenix, Arizona, United States

🇺🇸

Little Rock Hematology Oncology Assoc., Little Rock, Arkansas, United States

and more 59 locations

Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma

Phase 2
Terminated
Conditions
Ovarian Neoplasms
First Posted Date
2002-04-29
Last Posted Date
2007-12-18
Lead Sponsor
Unither Pharmaceuticals
Target Recruit Count
102
Registration Number
NCT00034372
Locations
🇺🇸

Gynecologic Oncology Associates, Newport Beach, California, United States

🇺🇸

Stanford University Medical Center, Stanford, California, United States

🇺🇸

Walt Disney Memorial Cancer Institute, Orlando, Florida, United States

and more 14 locations

A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma

Phase 1
Terminated
Conditions
Ovarian Neoplasms
First Posted Date
2002-04-24
Last Posted Date
2007-12-18
Lead Sponsor
Unither Pharmaceuticals
Target Recruit Count
24
Registration Number
NCT00034138
Locations
🇺🇸

Women's Cancer Research Foundation, Miami, Florida, United States

🇺🇸

Walt Disney Memorial Cancer Institute, Orlando, Florida, United States

🇺🇸

St. Joseph's Medical Center, South Bend, Indiana, United States

and more 5 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.